In addition, CXCL6 is a chemokine with neutrophil chemotaxis, and it has been reported that CXCL6 expression is observed in acute lung inflammation caused by bleomycin administration and lung injury caused by nanomaterials [51, 52]. Here, CXCL6 is linked to inflammatory response.